AIM ImmunoTech

YTD

ALL

Why Robinhood?

You can watch AIM ImmunoTech and buy or sell other stocks, ETFs, and their options commission-free!

About AIMI

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.

CEO

Thomas Kenwood Equels

CEOThomas Kenwood Equels

Employees

Employees23

Headquarters

Ocala, Florida

HeadquartersOcala, Florida

Founded

1966

Founded1966

Employees

Employees23

AIMI Key Statistics

Market cap

51.40K

Market cap51.40K

Price-Earnings ratio

-0.38

Price-Earnings ratio-0.38

Dividend yield

—

Dividend yield—

Average volume

2.68K

Average volume2.68K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$42.95

52 Week high$42.95

52 Week low

$2.51

52 Week low$2.51

People also own

Based on the portfolios of people who own AIMI. This list is generated using Robinhood data, and it’s not a recommendation.